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I!hwagation fa,:tor 2 (l!F-2l of rabbit rcti~:ulo~ytc,~ w.,ls phosphoryhtted ill ~,itro by im:ubation with partially pul'ilicd Et".2 kinase and [7-UP]ATP, 
After cxh;~ustive tryptic hydrolysis 4 pho~phopeptidc, s were. revealed by twtJ.dimetlsh)tml i~ptid¢ luappins, The phosph¢~peptides ~,-ere i'~olated by 
high Derform.'utce iiqtfid dlronlatography and sequenced. A comparison of the primary structure of the phospht)peptides with thai of EF-2 showed 
Ihal all ,1 pho~phopeptides originated fron't one region of F.F.2 located near the N.ierlninus that contains 3 Ihreonine residues: Thr.53, Thr.56, 
'l'hr-58. A direct cstilllafioll oflocitlitation ollradioactive phosphate in tile phosphoP~l~tides detnollstrat,:d fll.'lt all the enumerated thr¢oninc tc~ithl¢,,. 
in ['.'F-2 can be phosplu~rylated in vitro, 
Eltmgation factor 2; Phosphorylatiol~; I:H:-2 kitmsc; 'rryptic p iOsl~hopeptide 
1, INTROI)UCTION 
Elongation of polypeptide chains on ribosomes is 
catalyzed by the two elongation factors: EF-I and EF-2. 
EF-I is responsible for codon-dependent binding of 
aminoaeyl-tRNA to the ribosome, while EF-2 promotes 
translocation [1=3]. 
It has been shown that EF-2 is phosphorylated bya 
specific Ca z +/calmodulin.dependent EF-2 kinase [4-8] 
at threonine residues [5,7]. Phosphorylation results in 
EF-2 inactivation and the inhibition of protein biosyn- 
thesis [7-10]. The phosphory!ation itself is controlled 
by nerve growth factor [11-13], and thus can be con- 
sidered as a physiological mechanism controlling the 
rate of protein synthesis at the elongation step. 
Nairn and Palfrey [6] isolated one EF-2-derived 
phosphopeptide, Ala40-.Arg-59, containing 3 three- 
nine residues, but the location of the phosphate group 
in this study was not determined. 
Here we report data demonstrating that EF-2 
phosphorylation in vitro proceeds at 3 threonine 
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residues (Thr.53, Thr-56, and Thr-58) in the N-terminal 
part of the molecule. 
2. MATERIALS AND METHODS 
2, I, Isolation of EF.2 
EF'.2 was isolated from the posttribosomai supt:rnatant of rabbit 
rcticulocytes according to [9], Protein was quantified by amino bl,'~ck 
staining on nitrocellulose filters [14], 
2,2, Partial purification of El;:2 Mnase 
The posttnbosontal supgrnatam of rabbit reticulocytes was applied 
to a DI2AE-cellulose column, equilibrated with 10 mM Tris.HCl (pH 
7,6), 1 mM MgCI.., 50 mM KCI, 7 ram B.mercaptoethanol and 10% 
glycerol. EF.2 kinase was eluted with 600 n~M KCI, dialyzed, and up. 
plied to a column of hydrox;ttpatite, quilibrated with 10 mM 
potassium phosphate (pH 7,0), containing 3,5 mM /~-mercapto. 
ethanol and 10% glycerol. The kinase was eluted with a 10-300 mM 
potassium phosphate (pH 7,0) linear gradient, 
2,3, Phosphorylation of EF.2 
The reaction mixture (final volam~ l ml), containing 50 mM Hopes. 
KOH (pH 7,5), I0 mM MgAc2, 0,15 mM CaCI2) S mM DDT, I0 #g 
calmodulin, I(X) #g (I nmol) of EF-2, 20 ~g of the EF-2 kinase 
preparation (specific activity, 4,3 stool/rag/rain) and 0.$ mM 
[-r.~2P]ATP (4000 cpm/pmol) was incubated for I h at 3S°C. 
2,4. Trypsin hydrolysis of EF.2 
EF-2 after phosphorylation was dialyzed against 109 ml NH4HCO~ 
(pH 8,3) with 5 mM ~-mercaptoethanol, denatured by 2 rain heating 
at 70°C and incubated with trypsin (EF-2:enzyme ratio, 50:1) for 2 h 
at 37°C. A new portion of trypsin was then added in the same ratio 
to protein, and the incubation was continued for 18 h, 
2.5, Two.dimensional peptide mapping 
After trypsinolysis, the preparations (0.1 nmol of the initial pro- 
tein) were lyophilized, suspended in 50% pyridine in water and ap- 
plied onto thin-layer cellulose plates, Electrophoresis proceeded for 
90 rain, 800 V at pH 3.6 in pyridine/acetic a id/water (10:100:890). 
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I.'i~. I. Two.dimcqsional Dcplid¢ tulip of tryptic I!F'.2 l)llosIfltoI~¢p. 
lides, The plate ,.,,'zts autoradh~Sral'dled for 6 h ill '" 7(.)'f.,', 
I':I) I'A ;),)',d rcd))'om;do~*.~phed o)~tile ( ~ ~:tdumn t; ti ~1~ a d~allow~: 
)!ritdi¢l)t, lhe  'co ~scl v t)f '  P c,)talt'~ h~ the I I I ' I .C I~ttlific;tliOll ~'.;l~; 
|lt}l 1¢,, Ihdl~ t/tl¢'"~, 
2,7, ,~'¢(ltt¢;tt'i/t): '~/ Iryl~th' iblt~Jtplt~)l,~:/,ttd¢~ c*~d/¢ptttv Iltl(t,;'hcd tl) 
(lnstDtol~lh'llyl :(,l~,'~ 
Ih¢ IIlethod |Or ¢otlplhlg of  tl'.',pti,; ph,)',l)holSCl)tidc '~ It) 
alllhlol~hclD,'l g ils,~ tl[,-."~ ;uld ',,tlbxo, ltlelll ,~¢quetl,:hl.v. is I);v, cd el| the 
nlct hods Of [161 :Uld 1171 ;q~ dctcrilwd b,v WelteuhMI el at, I I a], A pOl'" 
lion (lip Io ,t0¢b) Of the I)otll~4,1 radio;~,.'tise pcpdde al~PCit)'ed to be 
collplcd tO ¢¢'ddu,d f)'c¢ itlllillol~|lCtt,VI tri¢fl}o,~.v~ila,e ',~'hi,:h ~a'~ 
g,r;lduall X ',,,a~hcd otlt of the ,~¢lluencer dllril lk; tile eat'IX c.v¢1¢'~, 
,,'~tllolll;I, lctl l idll l it l l  dc~fi ld; l l iOl l  ',~;l', I'~¢l'l't)l'llled tl*,ill E it p rOh)~o l  in 
~hi,:h the t2Ovill¢lll ilU:.lClllil¢lll of l~el~ib.lr', to ;tlltil'loDhcnyl g ;~ di,~c". 
cll~tl~lcd tl;e tls<" Of pt)lltr ,~OIv¢lll-. (lll¢lhitllol;ll:O, t,~);I{]) tO ¢XI1'~1¢1 
phOsl~hotyl dcrbalivc', froltl the i'e~'OdliOll u'arlridg¢ ;trier e~l,dll cycle t)f 
cleavaBe [i11,19], l'hc t\l'Z,atlthlo acid ¢lerixativc-. ~'ClrC collected 
directly front the curtridge, Illgllltl;llly converted to the Ctlfl'c'il~0ndJl)~t.: 
H' i  I.:tt'nhlo a¢id'h and almly/ctl by P.ILI llH,t' as tl¢*,crib¢;,I pl'¢viowi. 
ly 117,19). 
Ascetldin8 chromatosraphy wa.~ il| the pcrl)erltlicular direction in 
htltanolll)yridinct;tcctic a id/water (75:50:15:60), The plates were 
auh)radiographcd for 6-10 It at o- 70'C.  
2,6, ,Yelmration uml Imnfi¢'atios~ of  t.)hosphop(yJtides b,v RP.tlIJI, C 
Tryplic peptides (0,9 nmol initial protein) were separ:ned by Ri )- 
HPLC on a Ca column (liakcrbond, J T, tktker Chemical Co.) using 
an acetonitril¢ gr,tdicnt in 0,1070 (v/v) "rFA in water [151, )Zl'- 
r,tdioactivc l~eptides ,,.',',.:re identified by Cercnkov countin8, These 
peptide fr,'tctions were lyoplfilized, dissolved fit 0,10/0 TFA with 5 trim 
3, RU, SULTS AND DISCUSSION 
Incubat ion  o f  El;'-2 with EF-2 kinus~ and [,~,.S'~P]ATI ~ 
under  tile ¢ond i t ioas  descr ibed in section 2 g~wc an in- 
corporat ion  o f  1.3 tool o f  ~2p pet" 1 mot o f  prote in,  Th is  
ind icates that  more  thaa otle th reon ine  res idue in EF -2  
is phosphory la tec l ,  'Fhree n la jo r  artd otle tl l i l lor spots 
were regu lar ly  observed after exhaust ive  EF-2 t ryp-  
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Fig, 2. Rechromatography on RP.HPLC of EF.2 phosphopeptides. (a) Rechromatography of  fraction A; (b) rechromatography of  fraction B. Pep- 
tides were cluted at a flow rate of 0.~ ml/min with an increasing gradient of acetonitrile (indicated by the thin line) in aqueous 0.107o TFA. The 
thick line is from the tracing of absorbance at 215 nm, Radioactivity is indicated by filled circles, 
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To i,+olatc the pltU+l+hOl~cl+tide~, the lrypti¢ II~'dt'o. 
lys;tlc of the l~hosl~hol~yhttcd 1!I;'o2 v,':t,, chl'¢~lllattl~ 
t:ral~hctl by Rl'~dft'l .(' on ;t (', coltlwlll developed ~ith 
;tn acctonitrilc gr;ttlicttt (dater not i~fc~etHcd), Allottl 
h;dfof tile tt~tal r;tdioactivity ill the ILvdroly~at¢ ~v;t~ riot 
rcl;,tillCd ell tile cohllnll (pc;tk A). Ad,mrl~cd radk3;tctivi. 
ty wits ¢httcd itt lilt i|cctoltitriltr CollCctttr;ltiOll 0|' ~d'Jtlttl 
1,1% (l'Jc;tk II). 
Roclaronlatol,'.ral~hy o,  lilt? same cohlmll of t't'itctiOiI 
A injected ill a sohttiotl COlllaitting tI!I)'I'A altd tiling,', a 
rdtifllowcr ~,ratlient of :tcclonitrilc (Fig, 2u) rcstlltcd it~ 
the complete ads¢~rption of rlttlioactivity that wa~ then 
elutcd in 3 peaks by the ~raduul increase of the ac- 
tonitrile cottccntration. Dttring ~indlar rechrotuat,~- 
graph>' the radioactive I~eptidc of fraction 1~ w;~n clutcd 
~ts a single i~tmao~cncolts peak at a slightly lower 
~|cctonitrilc concentration than during the first 
chron~atot, raphy (Fig. 2b). Radioactive pcDtidcs, 
isolated ¢lurin8 rcchronuttogral~hY and clesit~'uatcd I 
(clutcd at 8°/'0 acctonitrilc), II (10.2% acctonitrile), III 
(11.5°:'o acctonitrile) ~.md IV (120:o ucctonitrile) as it~- 
dic~ttcd in Fig. 2a and b, respectively, were scqucttced. 
The results of sequencing and distribution of radioac- 
tivity arc shown in Fig, 3. 
Phosphopcptidc I ontains Phe in the first and Asp in 
the third positions and has two phosphorylated 
thrconine residues in the second and in the fourth posi- 
tions as seen from the ilacrcase of the radioactivity yield 
'.it the corresponding steps of sequencing (Fig. 3). 
Authentic PTH-threonine was not detected at these 
positions during the sequencing, a result that would be 
expected of modified threonine residues. PhosDhopep- 
tides II, III, IV start from Ala and have theconamon N- 
terminal sequence. 
The distribution of '~P-radioacti,Aty in the analysis 
of peptide II showed that this peptide contains three 
phosphorylated threonines. Cleat' 'bursts' of counts 
were observed at cycles corresponding with Thr-4 and 
-7. The relatively smaller increase at the position of 
Thr-9 was consistent with the residual PTH amino acids 
signals observed at the neighbouring positions. The 
signal at this position was reproducible (duplicate 
analyses) and was interpreted as evidence for pnos- 
phorylation of Thr-9. In fact, the effective release of 
counts at this position was made less evident by the 
premature release of some phosphopeptides at the pre- 
vious cycle which presumably was coupled through the 
Asp-8 carboxyl but not the carboxyl terminal residue. 
In the case of phosphopeptide III, only Thr.7 but not 
Thr-4 appeaered to be phosphorylated. Phosphopep- 
tide IV contains at least two radioactive threonines, 
Thr-4 and Thr-7, The bond between Arg-5-Phe-6 in 
phosphopeptides II, III and IV is not cleaved by trypsin 
presumably because of an inhibitory effect of the 
neighbouring phosphoryl groups on tryptie cleavage 
I201. 
A comparison of amino acid sequences of 
! a l l  ,, 
~f.,~ TFtI: AGE RF 
["iV,. 3, N-tcrn~il|al ',equel~c¢~ or Irypti¢ |l~l~]El:.2 i~ho,q~hopeptid,~ 
IdV, The figure sllows Iht~ ~"lJ.r,'ulioactivity relc;l~ed at each ¢yc1¢, 
l'h¢ radio'.tclivit y present in tile first ,;)'tie (parti¢lthtrly ~'ith peptides 
II, III, ;tl|d IV) rcprcsc¢lts washt+tlt of tll'tCOlll~led pcptid¢. Residues 
identified by IIPLC l"l'l+atllillo aehl qll:tlysc.',i ~.trc indic;trod alo,w, the 
X [ixis, 
phosphopel~tides I-IV with that of hamster EF.2 [21] 
shows that all phosphopeptidcs originate from one 
region of the EF-2 molecule (Fig. 4). It is known that 
the amino acid sequence of EF.2 is highly conserved in 
evolution. A difference in only two amino acid residues 
was detected between rat and hamster EF-2 [22]. The 
data of Fig. 4 indicate that 3 nearby threonine residues 
of EF-2 can be phosphorylated, namely Thr-53, Thr.56 
and Thr-58. We could not detect a radioactive peptide 
corresponding to Ala-50-Arg-54 indicating that a single 
phosphorylation even at Thr-53 may not occur. 
Recently 5 different isoelectric forms of the factor 
were found in a preparation of native EF-2 from rat 
liver. Three of these forms were shown to be 
phosphorylated EF-2 [23]. Thus, it is possible that all of 
the three threoninc residues (Thr-53, Thr-56, and 
Thr-58) that are phosphorylated in vitro in our ex- 
periments are targets for in rive phosphorylation. 
Several new questions arise in connection with the 
phosphorylation of the 3 amino acid residues of EF-2: 
(i) does a specific phosphorylation sequence of 
threonine residues exist for EF-2? If so what is the so, 
quence; (it) what is the extent of phosphorylation of 
each of these 3 residues in rive at different 
physiological states, and (iii) how does the functional 
activity of EF-2 depend on phosphorylation of each 
threonine residue7 
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